Sachem Capital Corp.
SACH NYSE Real Estate Investment Trusts Financials FY2016βFY2025
What Sachem Capital Corp. does
No business description yet.
- Legal name
- Sachem Capital Corp.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 13, 2026
- Accession Β· CIK
- 0001682220-26-000014
0001682220
Revenue and margins
Sachem Capital Corp. had $21.5M of revenue in fiscal 2025, down 62.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Sachem Capital Corp. returned $9.5M to shareholders in fiscal 2025. The diluted share count fell 1.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Sachem Capital Corp. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $103M | $48.3M | $50.4M | $19.6M | $11.9M |
| Debt incl. finance leases | β | $288M | $288M | $230M | β |
| Net debt / EBITDA | β | β | 15.6x | β | β |
| Debt / equity | β | 1.3x | 1.3x | 1.3x | β |
| Total assets | $418M | $566M | $621M | $492M | $460M |
| Total liabilities | $238M | $348M | $391M | $310M | $285M |
| Shareholders' equity | $180M | $218M | $230M | $182M | $175M |
| Net debt (β = net cash) | β | $240M | $238M | $211M | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 6 | 5 / 7 | 3 / 7 | β / 6 | β / 6 | β / 6 | 5 / 7 | 3 / 7 | β / 6 |
| Accruals ratio | β1.7% | 0.0% | 2.0% | β1.7% | β0.3% | β4.5% | 1.6% | β1.0% | β9.4% | 0.8% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $4.1M | $7.0M | $11.7M | $12.7M | $18.6M | $30.4M | $52.3M | $64.7M | $57.5M | $21.5M |
| Net interest income | β | β | β | β | β | β | β | β | $20.5M | $11.7M |
| Noninterest income | β | β | β | β | β | β | β | β | $9.4M | $9.9M |
| Provision for credit losses | β | β | β | β | β | β | $0.1M | $5.6M | $26.9M | $3.3M |
| Operating income | β | β | β | β | β | β | β | $15.0M | β$17.8M | β |
| Income tax | β | β | β | β | β | β | $0.0M | $0.0M | $0.2M | $0.0M |
| Net income | $3.1M | $4.9M | $7.8M | $6.2M | $9.0M | $13.3M | $20.9M | $15.9M | β$39.6M | $6.3M |
| Net income to common | β | β | β | β | $9.0M | $11.5M | $17.2M | $12.1M | β$43.9M | $1.8M |
| Diluted EPS | $0.00 | $0.38 | $0.50 | $0.32 | $0.41 | $0.44 | $0.46 | $0.27 | β$0.93 | $0.04 |
| Diluted shares | 0.00B | 0.00B | 0.02B | 0.02B | 0.02B | 0.03B | 0.04B | 0.04B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $3.7M | $4.8M | $6.2M | $8.1M | $9.6M | $27.8M | $13.1M | $21.9M | $12.9M | $2.7M |
| Capital expenditure | $0.0M | $0.1M | $0.7M | $0.2M | $0.1M | $0.8M | $1.6M | β | β | β |
| Free cash flow | $3.7M | $4.8M | $5.5M | $7.9M | $9.5M | $27.0M | $11.6M | β | β | β |
| Depreciation and amortization | $0.0M | $0.0M | $0.0M | $0.1M | $0.1M | $0.1M | $0.1M | $0.3M | $0.4M | $0.5M |
| Stock-based compensation | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.2M | $0.5M | $0.8M | $0.9M | $0.8M |
| Share buybacks | β | β | β | β | β | β | β | $0.2M | $1.5M | $0.0M |
| Dividends paid | β | β | β | β | $8.0M | $12.3M | $18.8M | $21.9M | $16.5M | $9.5M |
| Dividends and buybacks | β | β | β | β | $8.0M | $12.3M | $18.8M | $22.2M | $18.0M | $9.5M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.6M | $1.0M | $0.1M | $34.8M | $56.7M | $103M | $48.3M | $50.4M | $19.6M | $11.9M |
| Total debt | β | $0.3M | $0.3M | $0.8M | β | β | $288M | $288M | $230M | β |
| Finance lease liabilities | β | β | $0.0M | β | β | β | β | β | β | β |
| Loans, net | β | β | β | β | β | β | $461M | $492M | $357M | β |
| Property and equipment, net | $0.4M | $0.5M | $1.2M | $1.3M | $1.4M | $2.2M | $4.1M | $3.4M | $3.2M | $3.2M |
| Goodwill | β | β | β | β | β | β | $0.4M | $0.4M | $0.4M | $0.4M |
| Total assets | $38.4M | $67.5M | $86.0M | $141M | $227M | $418M | $566M | $621M | $492M | $460M |
| Total liabilities | $9.9M | $12.9M | $33.2M | $58.7M | $146M | $238M | $348M | $391M | $310M | $285M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $28.5M | $54.6M | $52.8M | $82.6M | $80.9M | $180M | $218M | $230M | $182M | $175M |
| Margins | ||||||||||
| Operating margin | β | β | β | β | β | β | β | 23.2% | β30.9% | β |
| EBITDA margin | β | β | β | β | β | β | β | 23.6% | β30.3% | β |
| Net margin | 73.8% | 69.5% | 66.3% | 48.9% | 48.3% | 43.8% | 40.0% | 24.6% | β68.8% | 29.3% |
| FCF margin | 89.4% | 67.9% | 47.0% | 62.1% | 51.0% | 88.7% | 22.1% | β | β | β |
| Net interest share of revenue | β | β | β | β | β | β | β | β | 35.6% | 54.2% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | β | 2.5% | β3.6% | β |
| Return on equity | 10.7% | 11.7% | 14.5% | 9.2% | 11.0% | 10.2% | 10.5% | 7.1% | β19.2% | 3.5% |
| Return on assets | 8.0% | 9.2% | 10.1% | 5.5% | 4.9% | 4.1% | 4.3% | 2.7% | β7.1% | 1.3% |
| Return on tangible equity | 10.7% | 8.9% | 14.7% | 7.5% | 11.1% | 6.4% | 7.9% | 5.3% | β24.2% | 1.1% |
| Growth | ||||||||||
| Revenue growth | β | 69.3% | 67.4% | 8.3% | 46.7% | 63.5% | 71.8% | 23.9% | β11.2% | β62.5% |
| Net income growth | β | 59.3% | 59.9% | β20.3% | 45.2% | 48.1% | 57.0% | β24.0% | β348.9% | β |
| EPS growth | β | β | 31.6% | β36.0% | 28.1% | 7.3% | 4.5% | β41.3% | β444.4% | β |
| FCF growth | β | 28.5% | 15.9% | 43.0% | 20.4% | 184.7% | β57.1% | β | β | β |
| Share count change | β | β | β | 25.9% | 13.9% | 19.0% | 43.4% | 17.2% | 7.2% | β1.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β | β | β | 15.6x | β | β |
| Debt / equity | β | 0.0x | 0.0x | 0.0x | β | β | 1.3x | 1.3x | 1.3x | β |
| Provision / loans | β | β | β | β | β | β | 0.0% | 1.1% | 7.6% | β |
| Capital allocation | ||||||||||
| Capex / revenue | 0.0% | 1.3% | 6.1% | 1.9% | 0.8% | 2.7% | 3.0% | β | β | β |
| Stock comp / revenue | β | 0.0% | 0.3% | 0.3% | 0.1% | 0.6% | 0.9% | 1.3% | 1.5% | 3.9% |
| Payouts / FCF | β | β | β | β | 84.0% | 45.5% | 162.6% | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 5.0 | 3.0 | β | β | β | 5.0 | 3.0 | β |
| Accruals ratio | β1.7% | 0.0% | 2.0% | β1.7% | β0.3% | β4.5% | 1.6% | β1.0% | β9.4% | 0.8% |
Source: SEC EDGAR XBRL filings (CIK 0001682220). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.